The contribution of Hind III C>G PAI-1 gene polymorphism in etiology of recurrent miscarriages.

OBJECTIVES The goal of the study was to assess the relationship of HindIII C>G PAI-1 gene polymorphism with increased risk of recurrent miscarriages. MATERIAL AND METHODS A whole of 152 women with a history of at least two miscarriages were classified into analysis. The study group was divided twice (114 subjects with 2 miscarriages and 38 subjects with >3 miscarriages, 123 subjects with miscarriages at <13gw, and 29 subjects with miscarriages in <21 gw). The controls consisted of 180 women with a positive history of at least one pregnancy and birth of a healthy term newborn, and a negative history of miscarriage. The analysed polymorphisms were determined by PCR/RFLP methods. RESULTS The occurrence of HindIII GG genotype in the whole study group was 25.7% and 20.0% in controls (OR= 1.38, p=0. 14). HindIII G allele was also observed more frequently in the whole study group (45.7% vs. 42.2% in controls, OR=1. 15, p=0.20). The occurrence of HindIII GG genotype was higher in the subgroup of women with >3 miscarriages (31.6% vs. 20.0% in controls, OR= 1.85, p=0.09). HindIII G allele was also noted more frequently in the subgroup of women with >3 miscarriages (50.0% vs. 42.2% in controls, OR=1.37, p=0. 13). A tendency of higher frequency of HindIII GG genotype and HindIII G allele was also noted in the subgroup of patients with miscarriages in the first and second trimester (HindIII GG: 31.0% vs. 20.0% in controls, OR= 1.80, p=O. 14, HindIII G: 51.7% vs. 42.2% in controls, OR=1.4 7, p=0.11). CONCLUSIONS Mutated HindIII G allele and HindIII GG genotype of HindIII C>G polymorphism probably augment the risk of recurrent miscarriages.

[1]  A. Bogacz,et al.  The -323P0/P10 factor VII gene polymorphism and the risk of recurrent miscarriage. , 2014, Ginekologia polska.

[2]  S. Tufik,et al.  Saturated Fatty Acid Intake Can Influence Increase in Plasminogen Activator Inhibitor-1 in Obese Adolescents , 2014, Hormone and Metabolic Research.

[3]  A. Seremak-Mrozikiewicz,et al.  [The 20210G>A and 19911A>G polymorphisms of prothrombin gene and recurrent miscarriages]. , 2013, Ginekologia polska.

[4]  R. Touraine,et al.  Plasminogen Activator Inhibitor 1 4G/5G and −844G/A Variants in Idiopathic Recurrent Pregnancy Loss , 2013, American journal of reproductive immunology.

[5]  Bo Eun Lee,et al.  Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women , 2013, Thrombosis and Haemostasis.

[6]  W. McGuire,et al.  Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review , 2013, PloS one.

[7]  H. Zeraati,et al.  Combination of Thrombophilic Gene Polymorphisms as a Cause of Increased the Risk of Recurrent Pregnancy Loss , 2012, Journal of reproduction & infertility.

[8]  B. Illades-Aguiar,et al.  Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children , 2012, BMC Pediatrics.

[9]  H. Rangel-Villalobos,et al.  Plasminogen activator inhibitor-1 polymorphisms (−844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables , 2011, Clinical and Experimental Medicine.

[10]  O. Christiansen,et al.  Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. , 2010, Human reproduction.

[11]  H. Rangel-Villalobos,et al.  Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis , 2009, Clinical and Experimental Medicine.

[12]  O. McGuinness,et al.  Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. , 2004, Diabetes.

[13]  L. Pereira-leite,et al.  Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre‐eclampsia: correlation with proteinuria , 2002, BJOG : an international journal of obstetrics and gynaecology.

[14]  J. Kooner,et al.  Association of Maternal Endothelial Dysfunction With Preeclampsia , 2001 .

[15]  C. Glueck,et al.  Genetic Hypofibrinolysis in Complicated Pregnancies , 2001, Obstetrics and gynecology.

[16]  T. Arinami,et al.  The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia , 2000, Journal of Human Genetics.

[17]  H. Grenett,et al.  Identification of the Hind III polymorphic site in the PAI-1 gene: analysis of the PAI-1 Hind III polymorphism by PCR. , 2000, Genetic testing.

[18]  A. Henney,et al.  Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.